This was in contrast to the levels of sensitive markers of inflammation, including IL-6 and LDH, which normalized in post–COVID-19 to levels of those in healthy donors, consistent with resolved acute inflammation (Figure 4D and Supplemental Table 1). Here, IL6 is linked to COVID-19.